This effect appeared to be due to activation of host P2X7 receptors, as PBMCs from human donors encoding either loss-of-function or gain-of-function P2RX7 gene variants resulted in similar rates and severity of GVHD (Adhikary et al., 2019). This evidence concerns the gene P2RX7 and graft versus host disease.